Tumor and Systemic Immunomodulatory Effects of MEK Inhibition

Dennison, L; Mohan, AA; Yarchoan, M

Yarchoan, M (corresponding author), Sidney Kimmel Comprehens Canc Ctr Johns Hopkins, Baltimore, MD 21231 USA.

CURRENT ONCOLOGY REPORTS, 2021; 23 (2):

Abstract

Purpose of Review Mitogen-activated protein kinase (MAPK) kinase (MEK) is an integral component of the RAS signaling pathway, one of the most frequent......

Full Text Link